Phase IV and RWE Services
“As your CRO and scientific service provider, OXON will plan and generate the highest quality Real-World data for Safety, Market access and Drug development.”
Our experts can help guide you through all available approaches, designs and implementation options for international field, database, and hybrid Real World Evidence studies to meet your needs in the most cost-efficient way.
OXON’s close links with centres of excellence at the London School of Hygiene & Tropical Medicine and Oxford University, leading pharmacoepidemiologists in the EU and Asia, as well as our outstanding publication record, including seven publications in The Lancet, and our initiatives at the EMA with ENCePP help us ensure the highest quality of our RWE studies.
Looking for help with your Phase IV study?
Let our team lend you a hand.
As a CRO specialising in late-phase research and RWE, we offer customized strategies and tailored processes designed to meet highly specific needs. We provide a compendium of services to help clients worldwide generate real-world evidence of product effectiveness, safety, and value to assist healthcare decisions and enhance patient care.